BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 34066744)

  • 1. Hepatitis B Virus Pre-S Gene Deletions and Pre-S Deleted Proteins: Clinical and Molecular Implications in Hepatocellular Carcinoma.
    Lin YT; Jeng LB; Chan WL; Su IJ; Teng CF
    Viruses; 2021 May; 13(5):. PubMed ID: 34066744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaches for Detection of Hepatitis B Virus Pre-S Gene Deletions and Pre-S Deleted Proteins and Their Application in Prediction of Higher Risk of Hepatocellular Carcinoma Development and Recurrence.
    Lin YT; Jeng LB; Su IJ; Teng CF
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35216021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B Virus Pre-S Mutants as Biomarkers and Targets for the Development and Recurrence of Hepatocellular Carcinoma.
    Teng CF; Wu HC; Su IJ; Jeng LB
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32859114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis.
    Wang HC; Huang W; Lai MD; Su IJ
    Cancer Sci; 2006 Aug; 97(8):683-8. PubMed ID: 16863502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in Qidong, China.
    Qu LS; Liu JX; Liu TT; Shen XZ; Chen TY; Ni ZP; Lu CH
    PLoS One; 2014; 9(5):e98257. PubMed ID: 24849936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.
    Chen CH; Hung CH; Lee CM; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Gastroenterology; 2007 Nov; 133(5):1466-74. PubMed ID: 17915220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma and hepatitis B surface protein.
    Li YW; Yang FC; Lu HQ; Zhang JS
    World J Gastroenterol; 2016 Feb; 22(6):1943-52. PubMed ID: 26877602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of a hepatitis B virus pre-S2 deletion mutant in the liver results in hepatomegaly and hepatocellular carcinoma in mice.
    Teng YC; Neo JC; Wu JC; Chen YF; Kao CH; Tsai TF
    J Pathol; 2017 Mar; 241(4):463-474. PubMed ID: 27868197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma.
    Chaturvedi VK; Singh A; Dubey SK; Hetta HF; John J; Singh MP
    Microb Pathog; 2019 Mar; 128():184-194. PubMed ID: 30611768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus pre-S/S variants in liver diseases.
    Chen BF
    World J Gastroenterol; 2018 Apr; 24(14):1507-1520. PubMed ID: 29662289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
    Chung YL; Wu ML
    J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel approach to identifying the hepatitis B virus pre-S deletions associated with hepatocellular carcinoma.
    Zhao ZM; Jin Y; Gan Y; Zhu Y; Chen TY; Wang JB; Sun Y; Cao ZG; Qian GS; Tu H
    World J Gastroenterol; 2014 Oct; 20(37):13573-81. PubMed ID: 25309088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B Virus Pre-S2 Mutant Induces Aerobic Glycolysis through Mammalian Target of Rapamycin Signal Cascade.
    Teng CF; Hsieh WC; Wu HC; Lin YJ; Tsai HW; Huang W; Su IJ
    PLoS One; 2015; 10(4):e0122373. PubMed ID: 25909713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased plasma levels of monocyte chemoattractant protein-1 in patients with hepatitis B virus pre-S2 gene deletion mutation predict a higher risk of hepatocellular carcinoma recurrence after curative surgical resection.
    Jeng LB; Li TC; Wang J; Teng CF
    Cancer; 2023 Sep; 129(17):2621-2636. PubMed ID: 37096803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine mapping of hepatitis B virus pre-S deletion and its association with hepatocellular carcinoma.
    Kao JH; Liu CJ; Jow GM; Chen PJ; Chen DS; Chen BF
    Liver Int; 2012 Oct; 32(9):1373-81. PubMed ID: 22676233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus mRNAs functionally sequester let-7a and enhance hepatocellular carcinoma.
    Deng M; Hou J; Hu J; Wang S; Chen M; Chen L; Ju Y; Li C; Meng S
    Cancer Lett; 2016 Dec; 383(1):62-72. PubMed ID: 27693636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different pre-S deletion patterns and their association with hepatitis B virus genotypes.
    Chen BF
    World J Gastroenterol; 2016 Sep; 22(35):8041-9. PubMed ID: 27672298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined core promoter mutations and pre-S deletion of HBV may not increase the risk of HCC: a geographical epidemiological study in Guangxi, China.
    Li GJ; Harrison TJ; Yang JY; Chen QY; Wang XY; Fang ZL
    Liver Int; 2013 Jul; 33(6):936-43. PubMed ID: 23517325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of hepatitis B virus reactivation on the recurrence of HBV-related hepatocellular carcinoma after curative resection in patients with low viral load.
    Sohn W; Paik YH; Cho JY; Ahn JM; Choi GS; Kim JM; Kwon CH; Joh JW; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    J Viral Hepat; 2015 Jun; 22(6):539-50. PubMed ID: 25377516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study.
    Chen CH; Changchien CS; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN
    J Infect Dis; 2008 Dec; 198(11):1634-42. PubMed ID: 18939932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.